OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Steven Schreiber

1 Projects | 1 Researchers | $130,000 Invested

2005

University of California, Irvine

Steven Schreiber, MD

Efficacy of the Histone Deacetylase Inhibitor, SAHA, in AD Transgenic Mice- A Proof-of-Concept Study

  • Funding Amount: $130,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed